DK0953046T3 - Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette - Google Patents

Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette

Info

Publication number
DK0953046T3
DK0953046T3 DK97918811T DK97918811T DK0953046T3 DK 0953046 T3 DK0953046 T3 DK 0953046T3 DK 97918811 T DK97918811 T DK 97918811T DK 97918811 T DK97918811 T DK 97918811T DK 0953046 T3 DK0953046 T3 DK 0953046T3
Authority
DK
Denmark
Prior art keywords
antigen
cell
hematopoietic stem
methods
progenitor cell
Prior art date
Application number
DK97918811T
Other languages
English (en)
Inventor
Sheri Miraglia
Wayne G Godfry
Amy Yin
David Buck
Original Assignee
Miltenyi Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/639,891 external-priority patent/US5843633A/en
Application filed by Miltenyi Biotec Gmbh filed Critical Miltenyi Biotec Gmbh
Application granted granted Critical
Publication of DK0953046T3 publication Critical patent/DK0953046T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/838—Marrow; spleen
DK97918811T 1996-04-26 1997-04-25 Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette DK0953046T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/639,891 US5843633A (en) 1996-04-26 1996-04-26 Characterization of a human hematopoietic progenitor cell antigen
US08/842,382 US6455678B1 (en) 1996-04-26 1997-04-23 Human hematopoietic stem and progenitor cell antigen
PCT/US1997/006930 WO1997041224A1 (en) 1996-04-26 1997-04-25 Human hematopoietic stem and progenitor cell antigen and methods for its use

Publications (1)

Publication Number Publication Date
DK0953046T3 true DK0953046T3 (da) 2009-08-10

Family

ID=27093419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918811T DK0953046T3 (da) 1996-04-26 1997-04-25 Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette

Country Status (10)

Country Link
US (4) US6455678B1 (da)
EP (1) EP0953046B1 (da)
JP (3) JP3908279B2 (da)
AT (1) ATE435282T1 (da)
AU (1) AU720938B2 (da)
CA (1) CA2251604C (da)
DE (1) DE69739480D1 (da)
DK (1) DK0953046T3 (da)
ES (1) ES2327691T3 (da)
WO (1) WO1997041224A1 (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US7361336B1 (en) * 1997-09-18 2008-04-22 Ivan Bergstein Methods of cancer therapy targeted against a cancer stem line
JP2004510951A (ja) * 1999-03-15 2004-04-08 イオス　バイオテクノロジー，インコーポレイティド 結腸直腸癌を診断する新規の方法、組成物、結腸直腸癌調節のためのスクリーニング法
ES2249058T3 (es) * 1999-12-30 2006-03-16 Imclone Systems Inc Factores de preservacion de celulas progenitoras y metodos y productos relacionados.
US6455668B1 (en) 2000-01-28 2002-09-24 Eos Biotechnology, Inc. Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US6566502B1 (en) 2000-01-28 2003-05-20 Eos Biotechnology, Inc. Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
US20070055367A1 (en) * 2000-03-15 2007-03-08 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US8460367B2 (en) * 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2001068158A1 (en) 2000-03-15 2001-09-20 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US6682890B2 (en) 2000-08-17 2004-01-27 Protein Design Labs, Inc. Methods of diagnosing and determining prognosis of colorectal cancer
WO2002044342A2 (en) 2000-10-18 2002-06-06 The Brigham And Women's Hospital, Inc. Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
EP1442115B9 (en) * 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
WO2003066097A2 (en) * 2002-02-08 2003-08-14 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel target to inhibit angiogenesis
US7381561B2 (en) 2002-08-27 2008-06-03 Stemcells California, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
US7252976B2 (en) * 2002-08-28 2007-08-07 Board Of Regents The University Of Texas System Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
AU2003296338A1 (en) * 2002-12-05 2004-06-30 Case Western Reserve University Cell-based therapies for ischemia
AU2004269395A1 (en) * 2003-08-27 2005-03-10 Stemcells California, Inc. Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
CA2563329C (en) * 2004-04-30 2016-01-26 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
WO2005123779A2 (en) * 2004-06-14 2005-12-29 The Board Of Trustees Of The University Of Illinois Antibodies binding to cd34+/cd36+ fetal but not to adult cells
CA2595695A1 (en) 2005-01-25 2006-08-03 Cell Therapeutics, Inc. Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
ES2711278T3 (es) 2005-12-29 2019-04-30 Celularity Inc Poblaciones de células madre placentarias
US20070266448A1 (en) * 2006-05-11 2007-11-15 Alexander Lifke Method for the production of antibodies
CA2700573C (en) 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
CA2700579A1 (en) 2006-09-28 2008-04-03 Cedars-Sinai Medical Center Cancer vaccines and vaccination methods
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
CA2732108A1 (en) 2008-07-28 2010-02-04 Children's Medical Center Corporation Prominin-1 peptide fragments and uses thereof
ES2565779T3 (es) * 2008-09-02 2016-04-06 Cedars-Sinai Medical Center Epítopos CD133
GB0823553D0 (en) * 2008-12-24 2009-01-28 Immunosolv Ltd Cell separation technique
WO2010129895A2 (en) * 2009-05-07 2010-11-11 Immunocellular Therapeutics, Ltd. Cd133 epitopes
WO2011094430A2 (en) * 2010-01-27 2011-08-04 Children's Medical Center Corporation Pro-angiogenic fragments of prominin-1 and uses thereof
WO2011149493A1 (en) 2010-05-26 2011-12-01 Regents Of The Unviversity Of Minnesota Single -chain variable fragment anti-cd133 antibodies and uses thereof
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
EP2673358B1 (en) 2011-02-08 2019-01-09 FUJIFILM Cellular Dynamics, Inc. Hematopoietic precursor cell production by programming
CN113559126A (zh) 2011-06-01 2021-10-29 人类起源公司 利用胎盘干细胞治疗疼痛
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
SG11201404608WA (en) 2012-02-13 2014-09-26 Gamida Cell Ltd Mesenchymal stem cells conditioned medium and methods of generating and using the same
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US10379026B2 (en) 2012-08-29 2019-08-13 Inguran, Llc Cell processing using magnetic particles
BR112015004374B1 (pt) 2012-08-29 2021-02-09 Inguran, Llc método de manipulação celular magnética
US20140234351A1 (en) 2013-02-14 2014-08-21 Immunocellular Therapeutics, Ltd. Cancer vaccines and vaccination methods
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
EP3656841A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3812769A1 (en) 2019-10-23 2021-04-28 Unicyte EV AG A method for in vitro diagnosis of renal glomerular disease or for monitoring the progression of renal glomerular disease
CN111560053B (zh) * 2020-06-17 2022-05-27 清华大学深圳国际研究生院 一种cd133拮抗多肽及其衍生物与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4714680B1 (en) 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
DE3787020T2 (de) * 1986-05-06 1993-12-16 Genetics Inst Herstellung von m-csf.
DE68919715T2 (de) 1988-12-28 1995-04-06 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
JPH02222686A (ja) * 1989-02-27 1990-09-05 Natl Food Res Inst マルトテトラオース生成酵素遺伝子
JP3205331B2 (ja) * 1989-03-14 2001-09-04 和光純薬工業株式会社 アクロモバクタープロテアーゼｉ類遺伝子及びその遺伝子産物
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
FR2696190B1 (fr) * 1992-09-25 1994-12-09 Agronomique Inst Nat Rech Acide nucléique codant pour une alpha-acétolactate synthase et ses applications.
DE4314342A1 (de) 1993-04-30 1994-11-03 Lido Duschabtrennung Prod Türbeschlag
EP0662512A3 (en) 1993-12-20 1997-01-15 Becton Dickinson Co Human hematopoietic stem cells.

Also Published As

Publication number Publication date
JP2006149396A (ja) 2006-06-15
AU720938B2 (en) 2000-06-15
AU2682197A (en) 1997-11-19
EP0953046A1 (en) 1999-11-03
US8084033B2 (en) 2011-12-27
US20010051372A1 (en) 2001-12-13
US20090093052A1 (en) 2009-04-09
ATE435282T1 (de) 2009-07-15
US6455678B1 (en) 2002-09-24
WO1997041224A1 (en) 1997-11-06
JP3908279B2 (ja) 2007-04-25
DE69739480D1 (de) 2009-08-13
ES2327691T3 (es) 2009-11-02
EP0953046B1 (en) 2009-07-01
CA2251604C (en) 2012-05-29
US20050214861A1 (en) 2005-09-29
JP2000509277A (ja) 2000-07-25
CA2251604A1 (en) 1997-11-06
JP2006246898A (ja) 2006-09-21

Similar Documents

Publication Publication Date Title
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
Wülling et al. The origin of the neoplastic stromal cell in giant cell tumor of bone
Machida et al. Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages
AU4981101A (en) Subtilisin variants
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
WO1998021334A3 (en) Antibody mg1 recognizing a small subset of human hematopoietic cells
RU2008126743A (ru) Способ получения фармацевтической композиции
AU3752795A (en) Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
ATE253631T1 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
PL350318A1 (en) Protein isolation and analysis
MY106507A (en) Antibody antagonists of human interleukin-4
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
Alipour et al. Phenotypic characterizations and comparison of adult dental stem cells with adipose-derived stem cells
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
HUP0301581A2 (hu) Sejteken prezentált peptidek
WO2002048403A3 (en) Multiplexed protein expression and activity assay
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
AP2368A (en) Novel expression vectors and uses thereof.
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
EP1211311A3 (en) Cord blood-derived activated lymphocytes and preparations containing said lymphocytes
Yim et al. Correlation between the immature characteristics of umbilical cord blood–derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
Kluth et al. Increased haematopoietic supportive function of USSC from umbilical cord blood compared to CB MSC and possible role of DLK-1
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav